Medical Resonance Therapy Music
Medical Resonance Therapy Music® – Scientific Studies & Clinical Observations
Vital Energy, Faster Recovery & Lower Drug Consumption
Faster Recovery of Pregnant Women at Risk with a Mild Form of the OPH-Syndrome

With the help of a cardiotocogram the heart activity of the fetus was investigated. The women were in the third trimester of pregnancy and suffered from a mild form of the OPH-syndrome (gestosis – nephropathy – with swellings at the feet, later at the whole body, hypertension, too much protein in urine) and the status of the fetal heart activity was problematic.


Medical Resonance Therapy Music® Group

For 7-10 days 13 women with an average age of 26 years (±0,6) listened to the Medical Resonance Therapy Music® in the morning and after lunch and had no other therapy dur­ing these days.

The cardiotocogram documented in 86% of the investigations a normalization of the state of the fetus.
This was also subjectively confirmed by the pregnants who felt better and better. Already after the 6th sitting accelerations and vari­abil­ity of fetal heart beat had improved docu­ment­ing an improved function of the fetal-pla­cen­tal system. Treatment could be ended af­ter 12 days (±1) in this group.


Control Group

14 women in this group received sedative and hypotensive drugs as well as a phy­to­thera­peu­tic treatment.

The state of the fetus also normalized after 6 treatments with drugs, but it took on average 3-4 days longer before the normal state was reached. The mean duration of treatment in this group was 14 days (±2).

Scientific Research on Medical Resonance Therapy Music
Investigators:
Dr. med. A. Kusnezowa
Prof. Dr. med. G. Gerassimowitsch
Prof. Dr. med. Walentina Sidorenko
Dr. med. Margarita Gawrisch
Dr. med. Tatjana Teterkina
Dr. med. Sergej Korotkow

Natural Medicine enters Scientific Medicine – through the doors of the Harmony Laws of the Microcosm of Music



With kind permission of AAR EDITION INTERNATIONAL – © 1998- SCIENTIFIC MUSIC MEDICINE | Contact
Subject to change in the interests of scientific advancement.